Abstract
AbstractBoth the racemic and the stereoselective synthesis of the silicon‐modified amino acid p‐(tBu2FSi)C6H4CH2(NH2)COOH (SiFA‐phenylalanine, 6) and its derivatives p‐(tBu2FSi)C6H4CH2(NHBoc)COOH (10) and p‐(tBu2FSi)C6H4CH2(NHFmoc)COOH (11) are reported. The latter two compounds are valuable building blocks for the convenient introduction of silicon‐based fluoride acceptors (SiFAs) into peptides by solid‐phase peptide syntheses (SPPS). As prove of principle, the Tyr3‐octreotate derivatives 12, 13 and 14 were prepared by using standard protocols of the solid‐phase peptide synthesis (SPPS). They were labelled with 18F‐fluorine by isotopic exchange in radiochemical yields of up to 70 % (with radiochemical purity ranging between 92 and 99 %). The incorporation of 18F‐fluorine into the SiFA‐modified amino acid 6 was studied as the latter may also serve as a tracer in PET. After purification, [18F]‐6 showed a remarkable stability in an isotonic solution. Also reported is the molecular structure, as determined by single‐crystal X‐ray diffraction analysis, of p‐(tBu2FSi)C6H4CHCH[C(O)OMe]NHC(O)OCH2Ph (8), which serves as a precursor for the stereoselective synthesis of compound 6.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.